Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial

  • Takeru Shiroiwa1Email author,
  • Takashi Fukuda1,
  • Kojiro Shimozuma2,
  • Mitsuko Mouri3,
  • Yasuhiro Hagiwara4,
  • Takuya Kawahara4, 5,
  • Shozo Ohsumi6,
  • Yasuo Hozumi7, 8,
  • Yoshiaki Sagara9,
  • Yasuo Ohashi10 and
  • Hirofumi Mukai11
BMC Cancer201717:773

https://doi.org/10.1186/s12885-017-3774-7

Received: 19 June 2017

Accepted: 13 November 2017

Published: 17 November 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
19 Jun 2017 Submitted Original manuscript
12 Jul 2017 Reviewed Reviewer Report - Frank G. A. Jansman
25 Jul 2017 Reviewed Reviewer Report - Jeonghoon Ahn
13 Aug 2017 Reviewed Reviewer Report - Rei Goto
30 Aug 2017 Author responded Author comments - Takeru Shiroiwa
Resubmission - Version 2
30 Aug 2017 Submitted Manuscript version 2
1 Sep 2017 Reviewed Reviewer Report - Frank G. A. Jansman
1 Sep 2017 Reviewed Reviewer Report - Jeonghoon Ahn
13 Sep 2017 Reviewed Reviewer Report - Rei Goto
28 Sep 2017 Author responded Author comments - Takeru Shiroiwa
Resubmission - Version 3
28 Sep 2017 Submitted Manuscript version 3
2 Oct 2017 Reviewed Reviewer Report - Frank G. A. Jansman
12 Oct 2017 Author responded Author comments - Takeru Shiroiwa
Resubmission - Version 4
12 Oct 2017 Submitted Manuscript version 4
4 Nov 2017 Author responded Author comments - Takeru Shiroiwa
Resubmission - Version 5
4 Nov 2017 Submitted Manuscript version 5
9 Nov 2017 Author responded Author comments - Takeru Shiroiwa
Resubmission - Version 6
9 Nov 2017 Submitted Manuscript version 6
Publishing
13 Nov 2017 Editorially accepted
17 Nov 2017 Article published 10.1186/s12885-017-3774-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Health and Welfare Services, National Institute of Public Health
(2)
Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University
(3)
Kanagawa Academy of Science and Technology (KAST)
(4)
Department of Biostatistics, School of Public Health, The University of Tokyo
(5)
Biostatistics Division, Clinical Research Support Center, The University of Tokyo Hospital
(6)
Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center
(7)
Department of Breast and Endocrine Surgery, University of Tsukuba Hospital
(8)
Department of Breast Surgery, Ibaraki Prefectural Central Hospital
(9)
Breast Surgery Department, Social Medical Corporation Hakuaikai Sagara Hospital
(10)
Department of Integrated Science and Engineering, Chuo University
(11)
Division of Breast and Medical Oncology, National Cancer Center Hospital East

Advertisement